Neil William Aubuchon
Chief Commercial Officer · Viking Therapeutics, Inc.
- 2026
- Mar 10, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil William Aubuchon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Lian - $14.00M in VKTX purchases and sales in the last 12 months
- Greg Zante - $2.82M in VKTX purchases and sales in the last 12 months
- Marianna Mancini - $2.73M in VKTX purchases and sales in the last 12 months
- Charles A. Rowland Jr. - $2.13M in VKTX purchases and sales in the last 12 months
- Matthew W. Foehr - $562K in VKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil William Aubuchon?
Neil William Aubuchon is a corporate insider, tracked as Chief Commercial Officer of Viking Therapeutics, Inc. (VKTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Neil William Aubuchon last file a Form 4?
The most recent primary Form 4 on record is dated 10 March 2026, one of 2 filings going back to 2026.
Has Neil William Aubuchon been buying or selling stock?
Recorded transactions: 1 open-market purchase ($150K) and 0 open-market sales across all tracked filings.
